Mechanism of Interferences for Gas Chromatography/Mass Spectrometry Analysis of Urine for Drugs of Abuse*F

Total Page:16

File Type:pdf, Size:1020Kb

Mechanism of Interferences for Gas Chromatography/Mass Spectrometry Analysis of Urine for Drugs of Abuse*F ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 25, No. 4 Copyright © 1995, Institute for Clinical Science, Inc. Mechanism of Interferences for Gas Chromatography/Mass Spectrometry Analysis of Urine for Drugs of Abuse*f ALAN H. B. WU, Ph.D. Toxicology Laboratory, Hartford Hospital, Hartford, CT 06102 ABSTRACT Although gas chromatography/mass spectrometry (GS/MS) is recognized as the definitive procedure for confirming positive immunoassay screening results of urine for drugs of abuse, targeted GC/MS analysis does have limitations. False negative results can occur when interfering drugs are present at high relative concentrations. If an interfering drug competes with the targeted drug for the derivatization reagent, low results are pro­ duced. If the interfering drug chromatographically co-elutes with the target drug, the ionization efficiency of the target compound by electron impact (El) ionization may be affected. False positive results can also occur through a number of mechanisms. Two substances with the same mass spectrum require gas chromatographic conditions that enable adequate separation of the compounds prior to MS analysis. In the case of optical isomers, special columns or derivatives must be used for identification and quantification. The widespread use of selected ion monitoring may further limit GC/MS assays. Drugs that produce similar high molecular-weight mass fragment ions could potentially interfere if they have similar GC retention times and if inappropriate ions are selected for monitoring. The conversion of one drug to another by the GC/MS instrument itself is a particularly insidious problem. False positive and negative results have serious forensic consequences and must be recognized and avoided. In contrast, the consumption of poppy seeds or meats from livestock given drugs such as methenolone can produce unexpected true positive results for opiates and anabolic steroids, respectively. Introduction for drugs of abuse, most laboratories use a combination of screening using a non­ Although there are many methods isotopic immunoassay and confirmation available today for the analysis of urine by gas chromatography/mass spectrome­ try. Many consider GC/MS as the “gold * Presented in part at the 1994 Spring Meeting of standard” for confirmation analysis. The the Association of Clinical Scientists, Charleston, SC. Substance Abuse and Mental Health Ser­ t Send reprint requests to: Alan H. B. Wu, Ph.D., Toxicology Laboratory, 80 Seymour Street, P.O. vices Administration (SAMHSA) man­ Box 5037, Hartford, CT 06102-5037. dates the use of targeted GC/MS analysis 319 0091-7370/95/0700-0319 $01.80 © Institute for Clinical Science, Inc. 320 wu for confirming positive results of urine Methodology collected for workplace testing of federal em ployees . 1,2 A “ targeted analysis” is F a l s e N e g a t i v e R e s u l t s directed towards determining the absence or quantitative presence of only Competition for derivatization rea­ a few drugs. This is in contrast to an gents. An important step for most GC/MS “unknown analysis” where the objective assays is derivatization of the target drug. is to identify the presence of as many Derivatization functions to increase the drugs or substances as possible. Most volatility of the substance, improve the laboratories use selected ion monitoring efficiency of chromatographic elution, (SIM) for targeted analysis because this and increase the molecular weight of improves the analytical sensitivity of the mass fragments so that they are more dis­ assay.3 Analysis, by SIM usually involves tinct from low molecular weight “back­ monitoring the intensity of three princi­ ground” mass fragments. Derivatization pal ions of a mass spectrum and comput­ reagents react with specific functional ing ion ratios of responses between ions. groups on the parent molecule including Full-scan mass spectral analysis coupled amides, amines, acids, and hydroxides.4 with a computerized library and search Accurate GC/MS analysis requires routines are necessary for conducting derivatization reactions that are stoichio- unknown analyses. metrically complete, as underivatized Data from GC/MS analysis are consid­ drugs elute at different times and would ered the most defensible in legal pro­ not be detected by analyses targeted ceedings. Some attorneys and lay indi­ towards the derivative. viduals might consider such analyses to As an example of drug interference be beyond challenge. However, GC/MS caused by competition, Brunk described is like any other analytical technique, the GC/MS analysis of the marijuana and there are important limitations. In metabolite 11-nor-A9 -THC-9-carboxylic this paper, mechanisms for false negative acid (9-carboxy THC [tetrahydrocan- and positive results of GC/MS analysis nabinols] ) . 5 As shown in figure 1, this for drugs of abuse are reviewed from assay involves the formation of the published reports. dimethyl derivative with dimethylsulfoxide c h 3 c « 3 (CH 3 )2 CHCH 2 ^ > -C H C O O H (CH 3 )2 CHCH 2 CHCOOCH 3 COOH delta-9-THC F ig u r e 1. The presence of ibuprofen can compete with delta-9-THC (tetrahydrocannabinols) for the formation of methyl derivatives. MECHANISM OF INTERFERENCES FOR GC/MS OF URINE FOR DRUGS OF ABUSE 321 (DMSO) and tétraméthylammonium excess to the other, saturation of the ion­ hydroxide (TMAH). The presence of ization source can occur, resulting in a high concentration of ibuprofen inter­ decrease in the ionization efficiency of fered with the derivatization of 9-carboxy both compounds (figure 2B). Under these THC by competing with the derivatiza­ conditions, the concentration of the tar­ tion reagent. This problem can be elimi­ get drug may be dramatically decreased nated by using enough derivatizating by the presence of the interferant. The reagent so that it does not get depleted gas chromatograph normally separates when other potentially interferring drugs drugs from potential interferants so that are present. both are not simultaneously present Interference of the ionization source in the ionization chamber of the mass by coelution. A critical tenant for the spectrometer. However, if pre-analytical success of GC/MS analysis is that the separation does not occur, a substance interaction of a substance with the instru­ that coelutes with the target compound mentation is independent to the pres­ may produce an interference. ence of another substance.6 In figure 2A Specific examples of these interactions is depicted the production of positive have been reported .6 ,7 In one report, the ions and mass fragments from the bom­ detection of cocaine metabolite ben- bardment of electrons for two different zoylecgonine (BE, target compound) was drugs present in equal concentrations. interfered by the coelution of the antifun- The presence of drug A does not interfere gal drug fluconazole (interferant), pres­ with the ability of the electron stream to ent at much higher concentrations rela­ ionize drug B. However, if the concentra­ tive to BE .6 This situation was detected tion of one of the drugs is present in great because a positive immunoassay screen A. B. to MS F igu re 2. A. Two substances (A and B) present in equal and nonsaturating concentrations within the electron impact chamber of a mass spectrometer independently produce parent ions (Al, Bl) and fragments (A2, B2). B. Substance B is present at saturating concentrations relative to the target substance A. Under these conditions, some of the target drug and interferant are unable to be ionized by the electron beam or are unable to reach the filtering segment of the mass spectrometer. 322 wu for BE was unexpectedly negative by Once the presence of a coeluting inter­ GC/MS. In the second example (figure 3), fering compound has been detected, cor­ high concentrations of a methadone rection of false negative results can be metabolite interfered with detection and made by removal of the interférant itself quantitation of BE .7 As shown in figure 3, prior to GC/MS analysis. In the example 2-ethylidene-l,5-dimethyl-3,3-diphenyl- presented in figure 3, EDDP was pyrrolidine (EDDP) coelutes with the removed by thin-layer chromatography cocaine metabolite, resulting in a very resulting in full recovery of BE from the small GC peak at m/z 300, corresponding sam ple.7 Another mechanisms to remove to the major fragment of the pentafluoro- interférants is to alter the gas chromato­ propionic (PFP) derivative of BE. graphic analysis conditions (e.g., chang­ The presence of a coeluting band is ing columns or temperature program) so very obvious when full scan MS analysis that the interférant no longer coelutes is used. In figure 3 is clearly illustrated with the target compound. This may not the presence of a large potentially inter­ always be possible, as interférant peaks fering chromatographic peak. When can be very broad. Moving the interférant selected ion monitoring mass spectro- may affect detection of other important metric techniques are used, however, substances such as drug metabolites. detection of an interférant is not apparent unless one (or more) of the ions selected for the target drug is coincidentally one F a l s e P o s i t i v e R e s u l t s of the major fragments of the interférant. This highlights the importance of using Substances with identical mass spec­ coeluting deuterated internal standards tra. Qualitative identification by mass (IS) . 8 The recovery of a coeluting internal spectrometry is predicated on the standard can be used to evaluate the assumption that no two compounds will quality of the GC/MS analysis, as the produce the identical mass spectrum. presence of a coeluting interférant will Although this may be theoretically true, affect the ionization efficiency of both the in actual practice, many pairs of com­ IS and target drug. Since a constant pounds have mass spectra that are essen­ amount of the IS is added to all samples, tially identical (i.e., within the limits of a low IS recovery might be caused by current instrumentation).
Recommended publications
  • Gas Chromatography-Mass Spectroscopy
    Gas Chromatography-Mass Spectroscopy Introduction Gas chromatography-mass spectroscopy (GC-MS) is one of the so-called hyphenated analytical techniques. As the name implies, it is actually two techniques that are combined to form a single method of analyzing mixtures of chemicals. Gas chromatography separates the components of a mixture and mass spectroscopy characterizes each of the components individually. By combining the two techniques, an analytical chemist can both qualitatively and quantitatively evaluate a solution containing a number of chemicals. Gas Chromatography In general, chromatography is used to separate mixtures of chemicals into individual components. Once isolated, the components can be evaluated individually. In all chromatography, separation occurs when the sample mixture is introduced (injected) into a mobile phase. In liquid chromatography (LC), the mobile phase is a solvent. In gas chromatography (GC), the mobile phase is an inert gas such as helium. The mobile phase carries the sample mixture through what is referred to as a stationary phase. The stationary phase is usually a chemical that can selectively attract components in a sample mixture. The stationary phase is usually contained in a tube of some sort called a column. Columns can be glass or stainless steel of various dimensions. The mixture of compounds in the mobile phase interacts with the stationary phase. Each compound in the mixture interacts at a different rate. Those that interact the fastest will exit (elute from) the column first. Those that interact slowest will exit the column last. By changing characteristics of the mobile phase and the stationary phase, different mixtures of chemicals can be separated.
    [Show full text]
  • 22 Chromatography and Mass Spectrometer
    MODULE Chromatography and Mass Spectrometer Biochemistry 22 Notes CHROMATOGRAPHY AND MASS SPECTROMETER 22.1 INTRODUCTION We know that the biochemistry or biological chemistry deals with the study of molecules present in organisms. These molecules are called as biomolecules and they form the basic unit of every cell. These include carbohydrates, proteins, lipids and nucleic acids. To study the biomolecules and to know their function, they have to be obtained in purified form. Purification of the biomolecules includes many physical and chemical methods. This topic gives about two of the commonly used methods namely, chromatography and mass spectrometry. These methods deals with purification and separation of biomolecules namely, protein and nucleic acids. OBJECTIVES After reading this lesson, you will be able to: z define the chromatography and mass spectrometry z describe the principle and important types of chromatographic methods z describe the principle and components of a mass spectrometer z enlist types of mass spectrometer z describe various uses of mass spectrometry 22.2 CHROMATOGRAPHY When we have a mixture of colored small beads, it is easily separated by visual examination. The same holds true for many chemical molecules. In 1903, 280 BIOCHEMISTRY Chromatography and Mass Spectrometer MODULE Mikhail, a botanist (person studies plants) described the separation of leaf Biochemistry pigments (different colors) in solution by using solid adsorbents. He named this method of separation called chromatography. It comes from two Greek words: chroma – colour graphein – to write/detect Modern separation methods are based on different types of chromatographic methods. The basic principle of any chromatography is due to presence of two Notes phases: z Mobile phase – substances to be separated are mixed with this fluid; it may be gas or liquid; it continues moves through the chromatographic instrument z Stationary phase – it does not move; it is packed inside a column; it is a porous matrix that helps in separation of substances present in sample.
    [Show full text]
  • Coupling Gas Chromatography to Mass Spectrometry
    Coupling Gas Chromatography to Mass Spectrometry Introduction The suite of gas chromatographic detectors includes (roughly in order from most common to the least): the flame ionization detector (FID), thermal conductivity detector (TCD or hot wire detector), electron capture detector (ECD), photoionization detector (PID), flame photometric detector (FPD), thermionic detector, and a few more unusual or VERY expensive choices like the atomic emission detector (AED) and the ozone- or fluorine-induce chemiluminescence detectors. All of these except the AED produce an electrical signal that varies with the amount of analyte exiting the chromatographic column. The AED does that AND yields the emission spectrum of selected elements in the analytes as well. Another GC detector that is also very expensive but very powerful is a scaled down version of the mass spectrometer. When coupled to a GC the detection system itself is often referred to as the mass selective detector or more simply the mass detector. This powerful analytical technique belongs to the class of hyphenated analytical instrumentation (since each part had a different beginning and can exist independently) and is called gas chromatograhy/mass spectrometry (GC/MS). Placed at the end of a capillary column in a manner similar to the other GC detectors, the mass detector is more complicated than, for instance, the FID because of the mass spectrometer's complex requirements for the process of creation, separation, and detection of gas phase ions. A capillary column is required in the chromatograph because the entire MS process must be carried out at very low pressures (~10-5 torr) and in order to meet this requirement a vacuum is maintained via constant pumping using a vacuum pump.
    [Show full text]
  • Four Channel Liquid Chromatography/Electrochemistry
    Four Channel Liquid Chromatography/Electrochemistry Bruce Peary Solomon, Ph.D. The new epsilon family of electrochemical detectors from BAS can Hong Long, Ph.D. Yongxin Zhu, Ph.D. control up to four working electrodes simultaneously. There are several Chandrani Gunaratna, Ph.D. advantages to using multiple detector electrodes. By using four different Lou Coury, Ph.D.* applied potentials with electrodes placed in a parallel arrangement, a Bioanalytical Systems, Inc. hydrodynamic voltammogram can be generated quickly through Corporate R&D Laboratories 2701 Kent Avenue acquisition of four data points for every analyte injection. This speeds West Lafayette, IN method development time. In addition, co-eluting compounds in complex 47906-1382 mixtures can be resolved on the basis of their observed half-wave * corresponding author potentials by using the same arrangement of electrodes, also in parallel. This article presents a few examples of four-electrode experiments performed with epsilon detectors in the BAS R&D labs during the past few months, using both radial-flow and cross-flow thin-layer configurations. The epsilon Platform the past fifteen years, our contract These instruments are fully network- research division, BAS Analytics, able and will be upgradable over the BAS developed and introduced the has provided analytical data of the Internet. New techniques and fea- first commercial electrochemical de- highest quality to the world’s leading tures may initially be ordered àla tector for liquid chromatography pharmaceutical companies using carte, or added at any time when the over twenty-five years ago. With this state-of-the-art products from BAS, need arises. In the coming months, issue of Current Separations,BAS as well as other leading vendors.
    [Show full text]
  • Complexometric Titration and Atomic Emission Spectroscopy) That Allow Us to Quantify the Amount of Each Metal Present Individually
    Title Quantitative Analysis of a Solution Containing Cobalt and Copper Name Manraj Gill (Lab partner: Tanner Adams) Abstract In this series of experiments, we determine the concentrations of two metal species, copper and cobalt, in a mixture of the two by initially using an ion exchange column to separate them from the mixture. We consequently use two different techniques (complexometric titration and atomic emission spectroscopy) that allow us to quantify the amount of each metal present individually. This step-by-step analysis not only goes through the basis for the experimental approach but also is a breakdown of the measurements that leads us to the final results: the Co:Cu ratio in the unknown mixture. Purpose In this series of three experiments (Parts I – III), we aim to initially separate a solution containing a mixture of Cobalt, Co (II), and Copper, Cu (II), ions in an unknown ratio and in unknown concentrations. The end goal of the entire experiment is to determine how much Co and Cu were originally present in the sample we obtained in Part I. But to do so, as explained in further detail in the ‘Theory and Methods’ section below, we initially separate the two ions (Part I) based on their unique chemical properties and then we attempt to quantify the separated ions through two different methods (Parts II, III). The overall purpose is an analysis of the efficiency of the separation and quantification approaches used to measure the constituent compounds in a mixture. This “efficiency” can be determined by comparing the obtained measurements to the known amounts that were used to make the solution.
    [Show full text]
  • Separation Science - Chromatography Unit Thomas Wenzel Department of Chemistry Bates College, Lewiston ME 04240 [email protected]
    Separation Science - Chromatography Unit Thomas Wenzel Department of Chemistry Bates College, Lewiston ME 04240 [email protected] LIQUID-LIQUID EXTRACTION Before examining chromatographic separations, it is useful to consider the separation process in a liquid-liquid extraction. Certain features of this process closely parallel aspects of chromatographic separations. The basic procedure for performing a liquid-liquid extraction is to take two immiscible phases, one of which is usually water and the other of which is usually an organic solvent. The two phases are put into a device called a separatory funnel, and compounds in the system will distribute between the two phases. There are two terms used for describing this distribution, one of which is called the distribution coefficient (DC), the other of which is called the partition coefficient (DM). The distribution coefficient is the ratio of the concentration of solute in the organic phase over the concentration of solute in the aqueous phase (the V-terms are the volume of the phases). This is essentially an equilibration process whereby we start with the solute in the aqueous phase and allow it to distribute into the organic phase. soluteaq = soluteorg [solute]org molorg/Vorg molorg x Vaq DC = --------------- = ------------------ = ----------------- [solute]aq molaq/Vaq molaq x Vorg The distribution coefficient represents the equilibrium constant for this process. If our goal is to extract a solute from the aqueous phase into the organic phase, there is one potential problem with using the distribution coefficient as a measure of how well you have accomplished this goal. The problem relates to the relative volumes of the phases.
    [Show full text]
  • HPLC Vs. UPLC
    HPLC vs. UPLC WHAT IS HPLC? A: HPLC is High Performance Liquid Chromatography, which is formerly referred to as high-pressure liquid chromatography. HPLC is one of the most dominant and widely used technologies used in analytical labora- tories for the last 30 years. HPLC system can handle pressure up to 6000 psi. WHAT IS UPLC? A: UPLC is Ultra Performance Liquid Chromatography. UPLC became the modern standard HPLC platform due to its power for increasing sample throughput, chromatographic efficiency, sensitivity and decreasing run time. UPLC system can handle pressure up to 15,000 psi. WHAT’S THE DIFFERENCE BETWEEN UPLC AND HPLC? A: Both HPLC and UPLC are both liquid chromatography techniques used to separate the different com- ponents found in mixtures. However, UPLC operates at higher pressures (15,000 psi) and allows for lower particle sizes in columns, while HPLC operates at lower pressures (max <6000 psi). UPLC improves analyte resolution and sensitivity, lower solvent consumption, and shorten run times. THE ADVANTAGE OF UPLC: UPLC can shorten run time to decrease TAT, provides “ better resolution to eliminate the potential impact from complicated matrix (See below Figure), and has higher sensitivity for low components analysis. HPLC - broader, wider peaks with some overlap at UPLC - sharper peaks with clear separation and peak the baseline level. specificity – clear lift-off and touch-down to peak. 1945 Fremont Drive dyadlabs.com Phone+1.801.973.8824 Salt Lake City, UT 84104 USA [email protected]@dyadlabs.com 1 HPLC vs. UPLC WHAT’S THE APPLICATION OF UPLC? A: The main purposes for using UPLC are for identifying and quan- tifying the individual components of the complicated samples (e.g.
    [Show full text]
  • Abiogenesis – the Emergence of Life for the Very First Time
    Abiogenesis – the emergence of life for the very first time. The question Darwin never addressed; was how life on Earth arose from inorganic matter; the so-called primordial soup. Consider, if life arose once on this planet, that would then mean that all life is related. Ultimately, humans and carrots have a common ancestor; the first proto-cell. Arrogant Worms tell it! Science always proceeds in fits and starts. Pasteur may have disproved abiogensis with his famous swan-neck flask experiments; he still believed that something about life was different. Pasteur believed that all metabolism including fermentation were special reactions that only occur in living organisms; i.e. there something special, maybe even supernatural to life. Pasteur believed that living things (the cells) contained a mysterious ―vital force‖. According to Pasteur, those marvelous macromolecules made by a cell could never be made in a test-tube. Pasteur was unaware of enzymes! Pasteur should have still known better. In 1828, F. Wöhler had reported the first chemical synthesis of a simple organic molecule (urea) from inorganic starting materials (silver cyanate and ammonium chloride). Organic Chemistry has not stopped since! We now think a pre-biotic mix of monomers and polymers accumulated somewhere on our planet. From this mixture rose life for the first and only time, a very very unlikely event – the first proto-cell - explaining why all life shares the same genetic code. How did these molecules first arise and how they were first assembled? Consider the Central Dogma of Genetics: The emergence of life for the first time on this planet constitutes the classic question of what came first; the chicken or the egg?! Did a self-replicating DNA system occur before transcription or translation evolved (the DNA World) or did a self-replicating RNA system first emerge (the RNA world) or did self-replicating protein system first emerge (the Protein World)…or did replication, transcription and translation emerge together all at once.
    [Show full text]
  • States of Origin: Influences on Research Into the Origins of Life
    COPYRIGHT AND USE OF THIS THESIS This thesis must be used in accordance with the provisions of the Copyright Act 1968. Reproduction of material protected by copyright may be an infringement of copyright and copyright owners may be entitled to take legal action against persons who infringe their copyright. Section 51 (2) of the Copyright Act permits an authorized officer of a university library or archives to provide a copy (by communication or otherwise) of an unpublished thesis kept in the library or archives, to a person who satisfies the authorized officer that he or she requires the reproduction for the purposes of research or study. The Copyright Act grants the creator of a work a number of moral rights, specifically the right of attribution, the right against false attribution and the right of integrity. You may infringe the author’s moral rights if you: - fail to acknowledge the author of this thesis if you quote sections from the work - attribute this thesis to another author - subject this thesis to derogatory treatment which may prejudice the author’s reputation For further information contact the University’s Director of Copyright Services sydney.edu.au/copyright Influences on Research into the Origins of Life. Idan Ben-Barak Unit for the History and Philosophy of Science Faculty of Science The University of Sydney A thesis submitted to the University of Sydney as fulfilment of the requirements for the degree of Doctor of Philosophy 2014 Declaration I hereby declare that this submission is my own work and that, to the best of my knowledge and belief, it contains no material previously published or written by another person, nor material which to a substantial extent has been accepted for the award of any other degree or diploma of a University or other institute of higher learning.
    [Show full text]
  • 7. High-Performance Liquid Chromatography (HPLC)
    CHEM 231 Lab Technique Primer 7. High-performance Liquid Chromatography (HPLC) While there are many analytical instruments found The sample is introduced into the HPLC system by in the typical chemical laboratory, perhaps the most way of an injector. When the injector is turned to common and most flexible is the HPLC. Based on the the “load” position (counterclockwise), a syringe is principle of chromatographic separation, HPLCs are used to fill up (or load) a sample loop of a precise used to determine the composition of complex volume. When the injector is then turned to the mixtures (such as plant extracts), to establish the “inject” position, the loop is placed in line with the provenance of artifacts (such as evidence at a crime column (Figure 3). scene), to gauge the extent of a reaction, or to verify 20 uL loop the purity of a product. The typical HPLC consists of four key components (Figure 1). Solvent is pumped at high pressure pump through a column packed with derivatized silica gel. solvent Upstream of the column is an injector to allow for column introduction of a sample. Downstream of the column is a detector (typically one that measures UV-Vis absorbance). injection port injector column pump solvent detector waste Figure 1. Basic components of the HPLC system 20 uL loop As individual components exit the column, they create an absorbance signal in the detector, resulting in a peak on the HPLC chromatogram pump (Figure 2). The y-axis of the chromatogram is a solvent measure of the intensity of absorbance (in units of column mAU, or milli-Absorbance Units).
    [Show full text]
  • Use of Microcalorimetry and Its Correlation with Size Exclusion
    APPLICATION NOTE Use of microcalorimetry and its correlation with size exclusion chromatography for rapid screening of the physical stability of large pharmaceutical proteins in solution Lori Burton; Rajesh Gandhi; Gerald Duke; Mehdi Paborji PROTEIN STABILITY Introduction During the past two decades, there has been a rapidly increasing interest in MICROCALORIMETRY development and commercialization of protein-based therapeutics. One of the greatest challenges during development for such products is the stabilization of proteins in PROTEIN AGGREGATION solution. To address this issue, many proteins are formulated as a lyophile that must be reconstituted with a suitable vehicle just prior to use. However, the preference for simpler administration procedures and reduced production costs make development of ready-to-use (RTU) solutions a particularly attractive approach for clinical and commercial drug product formulations, provided sufficient solution stability and adequate shelf life can be achieved. In addition, a large number of protein-based bulk drug substances are provided to development in solubilized form following purification, making identification of an appropriate buffer composition for storage and handling of the bulk protein an important step in the early development process. The studies required to support storage buffer recommendations and RTU solution development for protein pharmaceuticals can be timeconsuming and tedious and often require a significant amount of drug substance to conduct. The design of traditional solution stability studies involves storage of protein solutions of different concentrations in various buffer systems (with or without added excipients) under several stress temperature and/or lighting conditions. Samples of the solutions are then withdrawn periodically for analysis by one or more methods such as size exclusion chromatography (SEC), gel electrophoresis, and enzyme-linked immunosorbent assay (ELISA).
    [Show full text]
  • Ion Exchange Chromatography Principles and Methods GE Healthcare GE Imagination at Work at Imagination Ion Exchange Chromatography – Principles and Methods Q, Q
    GE Healthcare Ion Exchange Chromatography – Principles and Methods www.gelifesciences.com GE, GE monogram, Amersham, ÄKTA, AxiChrom, Biacore, BioProcess, Capto, Cy, CyDye, ECL, ECL Plex, ECL Select, FineLINE, HiPrep, HiScale, HiScreen, HiTrap, Hybond, MabSelect SuRe, MiniBeads, Mini Q, Mini S, MiniTrap, MonoBeads, Mono Q, Mono S, PhastGel, PhastSystem, PreDictor, PrimeView, Protran, ReadyToProcess, RESOURCE, Sephadex, Sepharose, SOURCE, SPARTAN, Superdex, Tricorn, UNICORN, and Whatman are trademarks of General Electric Company. Coomassie is a trademark of Thermo Fisher Scientific LLC, Gyrolab is a trademark of Gyros AB. RoboColumn is a trademark of Atoll GmbH. Triton is a trademark of Union Carbide Chemicals and Plastic Company Inc. Tween is a trademark of Croda Group of Companies. All other third-party trademarks are the property of their respective owners. Ion Exchange The purchase of CyDye products includes a limited license to use the CyDye products for internal research and development but not for any commercial purposes. A license to use the Cy and CyDye trademarks for commercial purposes is subject to a separate license agreement with GE Healthcare. Commercial use shall include: 1. Sale, lease, license or other transfer of the material or any material derived or produced from it. Chromatography 2. Sale, lease, license or other grant of rights to use this material or any material derived or produced from it. 3. Use of this material to perform services for a fee for third parties, including contract research and GE Healthcare Bio-Sciences AB drug screening. Principles and Methods Björkgatan 30 If you require a commercial license to use the Cy and CyDye trademarks please contact: [email protected].
    [Show full text]